nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP2D6—breast cancer	0.0992	0.538	CbGaD
Ciclesonide—CYP3A4—breast cancer	0.0851	0.462	CbGaD
Ciclesonide—CES1—Capecitabine—breast cancer	0.0659	0.193	CbGbCtD
Ciclesonide—NR3C1—Fluoxymesterone—breast cancer	0.0614	0.18	CbGbCtD
Ciclesonide—CES1—Tamoxifen—breast cancer	0.053	0.156	CbGbCtD
Ciclesonide—CES1—Irinotecan—breast cancer	0.0407	0.119	CbGbCtD
Ciclesonide—Testolactone—Exemestane—breast cancer	0.0383	0.117	CrCrCtD
Ciclesonide—Prednisone—Exemestane—breast cancer	0.0343	0.105	CrCrCtD
Ciclesonide—Loteprednol—Exemestane—breast cancer	0.0318	0.0971	CrCrCtD
Ciclesonide—Methylprednisolone—Exemestane—breast cancer	0.0297	0.0908	CrCrCtD
Ciclesonide—Prednisolone—Exemestane—breast cancer	0.0291	0.0889	CrCrCtD
Ciclesonide—Hydrocortamate—Fluoxymesterone—breast cancer	0.0282	0.0861	CrCrCtD
Ciclesonide—Testolactone—Fluoxymesterone—breast cancer	0.0265	0.081	CrCrCtD
Ciclesonide—Amcinonide—Fluoxymesterone—breast cancer	0.0244	0.0744	CrCrCtD
Ciclesonide—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0237	0.0725	CrCrCtD
Ciclesonide—Loteprednol—Fluoxymesterone—breast cancer	0.022	0.0673	CrCrCtD
Ciclesonide—Prednisolone—Fluoxymesterone—breast cancer	0.0202	0.0616	CrCrCtD
Ciclesonide—Hydrocortisone—Fluoxymesterone—breast cancer	0.0194	0.0591	CrCrCtD
Ciclesonide—CYP3A4—Exemestane—breast cancer	0.0124	0.0362	CbGbCtD
Ciclesonide—CYP2D6—Idarubicin—breast cancer	0.0112	0.0327	CbGbCtD
Ciclesonide—CYP3A4—Letrozole—breast cancer	0.0105	0.0308	CbGbCtD
Ciclesonide—CYP3A4—Anastrozole—breast cancer	0.00936	0.0275	CbGbCtD
Ciclesonide—CYP3A4—Toremifene—breast cancer	0.00856	0.0251	CbGbCtD
Ciclesonide—CYP3A4—Fulvestrant—breast cancer	0.00796	0.0234	CbGbCtD
Ciclesonide—CYP3A4—Thiotepa—breast cancer	0.00709	0.0208	CbGbCtD
Ciclesonide—CYP3A4—Ixabepilone—breast cancer	0.00649	0.019	CbGbCtD
Ciclesonide—CYP3A4—Lapatinib—breast cancer	0.00625	0.0183	CbGbCtD
Ciclesonide—CYP2D6—Vinorelbine—breast cancer	0.00545	0.016	CbGbCtD
Ciclesonide—CYP2D6—Tamoxifen—breast cancer	0.00492	0.0144	CbGbCtD
Ciclesonide—CYP3A4—Raloxifene—breast cancer	0.00473	0.0139	CbGbCtD
Ciclesonide—CYP3A4—Vinorelbine—breast cancer	0.00346	0.0102	CbGbCtD
Ciclesonide—CYP2D6—Vinblastine—breast cancer	0.00336	0.00985	CbGbCtD
Ciclesonide—CYP3A4—Tamoxifen—breast cancer	0.00313	0.00917	CbGbCtD
Ciclesonide—CYP3A4—Mitoxantrone—breast cancer	0.00305	0.00895	CbGbCtD
Ciclesonide—CYP3A4—Paclitaxel—breast cancer	0.00243	0.00714	CbGbCtD
Ciclesonide—CYP3A4—Irinotecan—breast cancer	0.0024	0.00704	CbGbCtD
Ciclesonide—CYP3A4—Vinblastine—breast cancer	0.00213	0.00626	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—breast cancer	0.00206	0.00605	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—breast cancer	0.00176	0.00516	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—breast cancer	0.00131	0.00385	CbGbCtD
Ciclesonide—SERPINA6—pituitary gland—breast cancer	0.000304	0.0581	CbGeAlD
Ciclesonide—CES1—adipose tissue—breast cancer	0.000303	0.0579	CbGeAlD
Ciclesonide—CES1—female reproductive system—breast cancer	0.000279	0.0532	CbGeAlD
Ciclesonide—SERPINA6—female reproductive system—breast cancer	0.000278	0.0532	CbGeAlD
Ciclesonide—CES1—adrenal gland—breast cancer	0.000272	0.052	CbGeAlD
Ciclesonide—SERPINA6—adrenal gland—breast cancer	0.000272	0.0519	CbGeAlD
Ciclesonide—SERPINA6—bone marrow—breast cancer	0.000263	0.0502	CbGeAlD
Ciclesonide—CES1—female gonad—breast cancer	0.000254	0.0484	CbGeAlD
Ciclesonide—NR3C1—nipple—breast cancer	0.000244	0.0466	CbGeAlD
Ciclesonide—CES1—endocrine gland—breast cancer	0.000236	0.0451	CbGeAlD
Ciclesonide—SERPINA6—endocrine gland—breast cancer	0.000236	0.045	CbGeAlD
Ciclesonide—Testolactone—CYP19A1—breast cancer	0.000233	0.186	CrCbGaD
Ciclesonide—NR3C1—embryo—breast cancer	0.000201	0.0384	CbGeAlD
Ciclesonide—NR3C1—epithelium—breast cancer	0.000164	0.0314	CbGeAlD
Ciclesonide—CES1—lymph node—breast cancer	0.000163	0.0311	CbGeAlD
Ciclesonide—NR3C1—skin of body—breast cancer	0.000156	0.0298	CbGeAlD
Ciclesonide—NR3C1—endometrium—breast cancer	0.000147	0.0281	CbGeAlD
Ciclesonide—NR3C1—uterus—breast cancer	0.000136	0.0259	CbGeAlD
Ciclesonide—NR3C1—pituitary gland—breast cancer	0.000133	0.0254	CbGeAlD
Ciclesonide—NR3C1—adipose tissue—breast cancer	0.000133	0.0253	CbGeAlD
Ciclesonide—NR3C1—female reproductive system—breast cancer	0.000122	0.0233	CbGeAlD
Ciclesonide—NR3C1—adrenal gland—breast cancer	0.000119	0.0227	CbGeAlD
Ciclesonide—NR3C1—bone marrow—breast cancer	0.000115	0.022	CbGeAlD
Ciclesonide—NR3C1—female gonad—breast cancer	0.000111	0.0212	CbGeAlD
Ciclesonide—Clobetasol propionate—CYP1A1—breast cancer	0.000105	0.0835	CrCbGaD
Ciclesonide—NR3C1—endocrine gland—breast cancer	0.000103	0.0197	CbGeAlD
Ciclesonide—Hydrocortisone—SHBG—breast cancer	9.74e-05	0.0776	CrCbGaD
Ciclesonide—CYP3A4—female reproductive system—breast cancer	9.22e-05	0.0176	CbGeAlD
Ciclesonide—CYP2D6—female reproductive system—breast cancer	9.08e-05	0.0173	CbGeAlD
Ciclesonide—Hydrocortamate—CYP3A4—breast cancer	8.57e-05	0.0683	CrCbGaD
Ciclesonide—CYP2D6—female gonad—breast cancer	8.26e-05	0.0158	CbGeAlD
Ciclesonide—Budesonide—CYP3A4—breast cancer	7.96e-05	0.0635	CrCbGaD
Ciclesonide—CYP3A4—endocrine gland—breast cancer	7.81e-05	0.0149	CbGeAlD
Ciclesonide—CYP2D6—endocrine gland—breast cancer	7.68e-05	0.0147	CbGeAlD
Ciclesonide—NR3C1—lymph node—breast cancer	7.13e-05	0.0136	CbGeAlD
Ciclesonide—Alclometasone—CYP3A4—breast cancer	6.86e-05	0.0547	CrCbGaD
Ciclesonide—Hydrocortisone—ABCG2—breast cancer	6.71e-05	0.0535	CrCbGaD
Ciclesonide—Flunisolide—CYP3A4—breast cancer	6.68e-05	0.0533	CrCbGaD
Ciclesonide—Paramethasone—CYP3A4—breast cancer	6.6e-05	0.0526	CrCbGaD
Ciclesonide—Methylprednisolone—CYP3A4—breast cancer	6.23e-05	0.0496	CrCbGaD
Ciclesonide—Pain in extremity—Epirubicin—breast cancer	5.6e-05	0.000589	CcSEcCtD
Ciclesonide—Haemoglobin—Capecitabine—breast cancer	5.59e-05	0.000588	CcSEcCtD
Ciclesonide—Nausea—Chlorambucil—breast cancer	5.59e-05	0.000587	CcSEcCtD
Ciclesonide—Rhinitis—Capecitabine—breast cancer	5.58e-05	0.000586	CcSEcCtD
Ciclesonide—Haemorrhage—Capecitabine—breast cancer	5.56e-05	0.000585	CcSEcCtD
Ciclesonide—Dizziness—Tamoxifen—breast cancer	5.54e-05	0.000582	CcSEcCtD
Ciclesonide—Pharyngitis—Capecitabine—breast cancer	5.52e-05	0.00058	CcSEcCtD
Ciclesonide—Urticaria—Thiotepa—breast cancer	5.43e-05	0.000571	CcSEcCtD
Ciclesonide—Face oedema—Epirubicin—breast cancer	5.41e-05	0.000568	CcSEcCtD
Ciclesonide—Headache—Vinblastine—breast cancer	5.4e-05	0.000567	CcSEcCtD
Ciclesonide—Angioedema—Paclitaxel—breast cancer	5.39e-05	0.000567	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Mitoxantrone—breast cancer	5.38e-05	0.000565	CcSEcCtD
Ciclesonide—Dizziness—Goserelin—breast cancer	5.29e-05	0.000556	CcSEcCtD
Ciclesonide—Rash—Tamoxifen—breast cancer	5.28e-05	0.000555	CcSEcCtD
Ciclesonide—Dermatitis—Tamoxifen—breast cancer	5.27e-05	0.000554	CcSEcCtD
Ciclesonide—Dyspnoea—Mitoxantrone—breast cancer	5.27e-05	0.000553	CcSEcCtD
Ciclesonide—Dyspnoea—Irinotecan—breast cancer	5.27e-05	0.000553	CcSEcCtD
Ciclesonide—Headache—Tamoxifen—breast cancer	5.24e-05	0.000551	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Gemcitabine—breast cancer	5.24e-05	0.000551	CcSEcCtD
Ciclesonide—Palpitations—Paclitaxel—breast cancer	5.22e-05	0.000548	CcSEcCtD
Ciclesonide—Dyspepsia—Mitoxantrone—breast cancer	5.2e-05	0.000546	CcSEcCtD
Ciclesonide—Dyspepsia—Irinotecan—breast cancer	5.2e-05	0.000546	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—breast cancer	5.19e-05	0.000545	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—breast cancer	5.18e-05	0.000545	CcSEcCtD
Ciclesonide—Methylprednisolone—ABCB1—breast cancer	5.18e-05	0.0413	CrCbGaD
Ciclesonide—Mediastinal disorder—Docetaxel—breast cancer	5.18e-05	0.000544	CcSEcCtD
Ciclesonide—Rash—Melphalan—breast cancer	5.17e-05	0.000543	CcSEcCtD
Ciclesonide—Dermatitis—Melphalan—breast cancer	5.16e-05	0.000543	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Fluorouracil—breast cancer	5.15e-05	0.000542	CcSEcCtD
Ciclesonide—Cough—Paclitaxel—breast cancer	5.15e-05	0.000541	CcSEcCtD
Ciclesonide—Asthenia—Vinorelbine—breast cancer	5.14e-05	0.00054	CcSEcCtD
Ciclesonide—Dyspnoea—Gemcitabine—breast cancer	5.13e-05	0.000539	CcSEcCtD
Ciclesonide—Nausea—Vinblastine—breast cancer	5.12e-05	0.000538	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Irinotecan—breast cancer	5.1e-05	0.000536	CcSEcCtD
Ciclesonide—Hypertension—Paclitaxel—breast cancer	5.1e-05	0.000535	CcSEcCtD
Ciclesonide—Fatigue—Irinotecan—breast cancer	5.09e-05	0.000535	CcSEcCtD
Ciclesonide—Fatigue—Mitoxantrone—breast cancer	5.09e-05	0.000535	CcSEcCtD
Ciclesonide—Dyspnoea—Fluorouracil—breast cancer	5.04e-05	0.00053	CcSEcCtD
Ciclesonide—Rash—Goserelin—breast cancer	5.04e-05	0.00053	CcSEcCtD
Ciclesonide—Dermatitis—Goserelin—breast cancer	5.04e-05	0.000529	CcSEcCtD
Ciclesonide—Immune system disorder—Capecitabine—breast cancer	5.03e-05	0.000528	CcSEcCtD
Ciclesonide—Arthralgia—Paclitaxel—breast cancer	5.03e-05	0.000528	CcSEcCtD
Ciclesonide—Chest pain—Paclitaxel—breast cancer	5.03e-05	0.000528	CcSEcCtD
Ciclesonide—Mediastinal disorder—Capecitabine—breast cancer	5.01e-05	0.000527	CcSEcCtD
Ciclesonide—Nasopharyngitis—Epirubicin—breast cancer	5.01e-05	0.000527	CcSEcCtD
Ciclesonide—Headache—Goserelin—breast cancer	5.01e-05	0.000526	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—breast cancer	5.01e-05	0.000526	CcSEcCtD
Ciclesonide—Dyspepsia—Fluorouracil—breast cancer	4.98e-05	0.000523	CcSEcCtD
Ciclesonide—Nausea—Tamoxifen—breast cancer	4.97e-05	0.000523	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Gemcitabine—breast cancer	4.97e-05	0.000522	CcSEcCtD
Ciclesonide—Fatigue—Gemcitabine—breast cancer	4.96e-05	0.000521	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Epirubicin—breast cancer	4.94e-05	0.000519	CcSEcCtD
Ciclesonide—Dry mouth—Paclitaxel—breast cancer	4.91e-05	0.000516	CcSEcCtD
Ciclesonide—Asthenia—Thiotepa—breast cancer	4.91e-05	0.000516	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—breast cancer	4.9e-05	0.000515	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Fluorouracil—breast cancer	4.88e-05	0.000513	CcSEcCtD
Ciclesonide—Nausea—Melphalan—breast cancer	4.87e-05	0.000512	CcSEcCtD
Ciclesonide—Influenza—Epirubicin—breast cancer	4.84e-05	0.000509	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—breast cancer	4.84e-05	0.000509	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Methotrexate—breast cancer	4.81e-05	0.000505	CcSEcCtD
Ciclesonide—Infection—Paclitaxel—breast cancer	4.79e-05	0.000503	CcSEcCtD
Ciclesonide—Prednisone—CYP3A4—breast cancer	4.76e-05	0.038	CrCbGaD
Ciclesonide—Nausea—Goserelin—breast cancer	4.75e-05	0.000499	CcSEcCtD
Ciclesonide—Dysgeusia—Capecitabine—breast cancer	4.74e-05	0.000498	CcSEcCtD
Ciclesonide—Dizziness—Vinorelbine—breast cancer	4.74e-05	0.000498	CcSEcCtD
Ciclesonide—Urticaria—Mitoxantrone—breast cancer	4.69e-05	0.000493	CcSEcCtD
Ciclesonide—Back pain—Capecitabine—breast cancer	4.69e-05	0.000492	CcSEcCtD
Ciclesonide—Bronchitis—Epirubicin—breast cancer	4.66e-05	0.000489	CcSEcCtD
Ciclesonide—Pneumonia—Methotrexate—breast cancer	4.64e-05	0.000488	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—breast cancer	4.64e-05	0.000487	CcSEcCtD
Ciclesonide—Infestation NOS—Methotrexate—breast cancer	4.61e-05	0.000485	CcSEcCtD
Ciclesonide—Infestation—Methotrexate—breast cancer	4.61e-05	0.000485	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—breast cancer	4.57e-05	0.00048	CcSEcCtD
Ciclesonide—Dizziness—Thiotepa—breast cancer	4.52e-05	0.000475	CcSEcCtD
Ciclesonide—Rash—Vinorelbine—breast cancer	4.52e-05	0.000474	CcSEcCtD
Ciclesonide—Dermatitis—Vinorelbine—breast cancer	4.51e-05	0.000474	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Epirubicin—breast cancer	4.5e-05	0.000473	CcSEcCtD
Ciclesonide—Urticaria—Fluorouracil—breast cancer	4.49e-05	0.000472	CcSEcCtD
Ciclesonide—Headache—Vinorelbine—breast cancer	4.49e-05	0.000471	CcSEcCtD
Ciclesonide—Conjunctivitis—Methotrexate—breast cancer	4.49e-05	0.000471	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—breast cancer	4.48e-05	0.000471	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—breast cancer	4.42e-05	0.000465	CcSEcCtD
Ciclesonide—Weight increased—Epirubicin—breast cancer	4.41e-05	0.000463	CcSEcCtD
Ciclesonide—Prednisolone—CYP3A4—breast cancer	4.39e-05	0.035	CrCbGaD
Ciclesonide—Musculoskeletal discomfort—Paclitaxel—breast cancer	4.39e-05	0.000461	CcSEcCtD
Ciclesonide—Cough—Docetaxel—breast cancer	4.37e-05	0.000459	CcSEcCtD
Ciclesonide—Epistaxis—Methotrexate—breast cancer	4.35e-05	0.000457	CcSEcCtD
Ciclesonide—Pneumonia—Epirubicin—breast cancer	4.34e-05	0.000456	CcSEcCtD
Ciclesonide—Hypertension—Docetaxel—breast cancer	4.32e-05	0.000454	CcSEcCtD
Ciclesonide—Infestation NOS—Epirubicin—breast cancer	4.32e-05	0.000454	CcSEcCtD
Ciclesonide—Infestation—Epirubicin—breast cancer	4.32e-05	0.000454	CcSEcCtD
Ciclesonide—Rash—Thiotepa—breast cancer	4.31e-05	0.000453	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—breast cancer	4.31e-05	0.000453	CcSEcCtD
Ciclesonide—Dermatitis—Thiotepa—breast cancer	4.31e-05	0.000453	CcSEcCtD
Ciclesonide—Dyspnoea—Paclitaxel—breast cancer	4.29e-05	0.000451	CcSEcCtD
Ciclesonide—Headache—Thiotepa—breast cancer	4.28e-05	0.00045	CcSEcCtD
Ciclesonide—Palpitations—Capecitabine—breast cancer	4.28e-05	0.00045	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—breast cancer	4.26e-05	0.000448	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—breast cancer	4.26e-05	0.000448	CcSEcCtD
Ciclesonide—Nausea—Vinorelbine—breast cancer	4.25e-05	0.000447	CcSEcCtD
Ciclesonide—Dyspepsia—Paclitaxel—breast cancer	4.24e-05	0.000446	CcSEcCtD
Ciclesonide—Asthenia—Mitoxantrone—breast cancer	4.24e-05	0.000445	CcSEcCtD
Ciclesonide—Asthenia—Irinotecan—breast cancer	4.24e-05	0.000445	CcSEcCtD
Ciclesonide—Cough—Capecitabine—breast cancer	4.23e-05	0.000444	CcSEcCtD
Ciclesonide—Conjunctivitis—Epirubicin—breast cancer	4.2e-05	0.000441	CcSEcCtD
Ciclesonide—Urinary tract infection—Epirubicin—breast cancer	4.2e-05	0.000441	CcSEcCtD
Ciclesonide—Hypertension—Capecitabine—breast cancer	4.18e-05	0.000439	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—breast cancer	4.17e-05	0.000438	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—breast cancer	4.16e-05	0.000438	CcSEcCtD
Ciclesonide—Haemoglobin—Methotrexate—breast cancer	4.16e-05	0.000437	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Paclitaxel—breast cancer	4.16e-05	0.000437	CcSEcCtD
Ciclesonide—Prednisone—ALB—breast cancer	4.15e-05	0.0331	CrCbGaD
Ciclesonide—Fatigue—Paclitaxel—breast cancer	4.15e-05	0.000436	CcSEcCtD
Ciclesonide—Haemorrhage—Methotrexate—breast cancer	4.14e-05	0.000435	CcSEcCtD
Ciclesonide—Asthenia—Gemcitabine—breast cancer	4.13e-05	0.000434	CcSEcCtD
Ciclesonide—Arthralgia—Capecitabine—breast cancer	4.12e-05	0.000433	CcSEcCtD
Ciclesonide—Chest pain—Capecitabine—breast cancer	4.12e-05	0.000433	CcSEcCtD
Ciclesonide—Pharyngitis—Methotrexate—breast cancer	4.11e-05	0.000432	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—breast cancer	4.08e-05	0.000429	CcSEcCtD
Ciclesonide—Epistaxis—Epirubicin—breast cancer	4.07e-05	0.000428	CcSEcCtD
Ciclesonide—Nausea—Thiotepa—breast cancer	4.06e-05	0.000427	CcSEcCtD
Ciclesonide—Infection—Docetaxel—breast cancer	4.06e-05	0.000426	CcSEcCtD
Ciclesonide—Sinusitis—Epirubicin—breast cancer	4.05e-05	0.000426	CcSEcCtD
Ciclesonide—Dry mouth—Capecitabine—breast cancer	4.03e-05	0.000424	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—breast cancer	4.02e-05	0.000422	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—breast cancer	4e-05	0.00042	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—breast cancer	4e-05	0.00042	CcSEcCtD
Ciclesonide—Prednisone—ABCB1—breast cancer	3.96e-05	0.0316	CrCbGaD
Ciclesonide—Infection—Capecitabine—breast cancer	3.93e-05	0.000413	CcSEcCtD
Ciclesonide—Dizziness—Irinotecan—breast cancer	3.91e-05	0.00041	CcSEcCtD
Ciclesonide—Haemoglobin—Epirubicin—breast cancer	3.9e-05	0.000409	CcSEcCtD
Ciclesonide—Rhinitis—Epirubicin—breast cancer	3.89e-05	0.000408	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—breast cancer	3.88e-05	0.000408	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—breast cancer	3.88e-05	0.000408	CcSEcCtD
Ciclesonide—Haemorrhage—Epirubicin—breast cancer	3.88e-05	0.000407	CcSEcCtD
Ciclesonide—Pharyngitis—Epirubicin—breast cancer	3.85e-05	0.000404	CcSEcCtD
Ciclesonide—Urticaria—Paclitaxel—breast cancer	3.83e-05	0.000402	CcSEcCtD
Ciclesonide—Epistaxis—Doxorubicin—breast cancer	3.77e-05	0.000396	CcSEcCtD
Ciclesonide—Sinusitis—Doxorubicin—breast cancer	3.75e-05	0.000394	CcSEcCtD
Ciclesonide—Immune system disorder—Methotrexate—breast cancer	3.74e-05	0.000393	CcSEcCtD
Ciclesonide—Dizziness—Fluorouracil—breast cancer	3.74e-05	0.000393	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methotrexate—breast cancer	3.73e-05	0.000392	CcSEcCtD
Ciclesonide—Rash—Mitoxantrone—breast cancer	3.72e-05	0.000391	CcSEcCtD
Ciclesonide—Rash—Irinotecan—breast cancer	3.72e-05	0.000391	CcSEcCtD
Ciclesonide—Dermatitis—Mitoxantrone—breast cancer	3.72e-05	0.000391	CcSEcCtD
Ciclesonide—Dermatitis—Irinotecan—breast cancer	3.72e-05	0.000391	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—breast cancer	3.72e-05	0.000391	CcSEcCtD
Ciclesonide—Headache—Mitoxantrone—breast cancer	3.7e-05	0.000389	CcSEcCtD
Ciclesonide—Headache—Irinotecan—breast cancer	3.7e-05	0.000389	CcSEcCtD
Ciclesonide—Prednisolone—ABCB1—breast cancer	3.65e-05	0.0291	CrCbGaD
Ciclesonide—Dyspnoea—Docetaxel—breast cancer	3.64e-05	0.000383	CcSEcCtD
Ciclesonide—Rash—Gemcitabine—breast cancer	3.63e-05	0.000381	CcSEcCtD
Ciclesonide—Dermatitis—Gemcitabine—breast cancer	3.62e-05	0.000381	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—breast cancer	3.61e-05	0.000379	CcSEcCtD
Ciclesonide—Headache—Gemcitabine—breast cancer	3.6e-05	0.000379	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Capecitabine—breast cancer	3.6e-05	0.000378	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—breast cancer	3.6e-05	0.000378	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—breast cancer	3.59e-05	0.000378	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—breast cancer	3.59e-05	0.000377	CcSEcCtD
Ciclesonide—Rash—Fluorouracil—breast cancer	3.57e-05	0.000375	CcSEcCtD
Ciclesonide—Dermatitis—Fluorouracil—breast cancer	3.56e-05	0.000374	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—breast cancer	3.56e-05	0.000374	CcSEcCtD
Ciclesonide—Headache—Fluorouracil—breast cancer	3.54e-05	0.000372	CcSEcCtD
Ciclesonide—Dysgeusia—Methotrexate—breast cancer	3.53e-05	0.000371	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—breast cancer	3.53e-05	0.00037	CcSEcCtD
Ciclesonide—Dyspnoea—Capecitabine—breast cancer	3.52e-05	0.00037	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—breast cancer	3.52e-05	0.00037	CcSEcCtD
Ciclesonide—Nausea—Mitoxantrone—breast cancer	3.51e-05	0.000369	CcSEcCtD
Ciclesonide—Nausea—Irinotecan—breast cancer	3.51e-05	0.000369	CcSEcCtD
Ciclesonide—Immune system disorder—Epirubicin—breast cancer	3.5e-05	0.000368	CcSEcCtD
Ciclesonide—Mediastinal disorder—Epirubicin—breast cancer	3.49e-05	0.000367	CcSEcCtD
Ciclesonide—Back pain—Methotrexate—breast cancer	3.49e-05	0.000366	CcSEcCtD
Ciclesonide—Dyspepsia—Capecitabine—breast cancer	3.48e-05	0.000366	CcSEcCtD
Ciclesonide—Asthenia—Paclitaxel—breast cancer	3.46e-05	0.000363	CcSEcCtD
Ciclesonide—Nausea—Gemcitabine—breast cancer	3.42e-05	0.000359	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Capecitabine—breast cancer	3.41e-05	0.000359	CcSEcCtD
Ciclesonide—Fatigue—Capecitabine—breast cancer	3.41e-05	0.000358	CcSEcCtD
Ciclesonide—Nausea—Fluorouracil—breast cancer	3.36e-05	0.000353	CcSEcCtD
Ciclesonide—Hydrocortisone—CYP3A4—breast cancer	3.36e-05	0.0268	CrCbGaD
Ciclesonide—Dysgeusia—Epirubicin—breast cancer	3.3e-05	0.000347	CcSEcCtD
Ciclesonide—Back pain—Epirubicin—breast cancer	3.26e-05	0.000343	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—breast cancer	3.24e-05	0.00034	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—breast cancer	3.23e-05	0.00034	CcSEcCtD
Ciclesonide—Dizziness—Paclitaxel—breast cancer	3.19e-05	0.000335	CcSEcCtD
Ciclesonide—Cough—Methotrexate—breast cancer	3.15e-05	0.000331	CcSEcCtD
Ciclesonide—Urticaria—Capecitabine—breast cancer	3.14e-05	0.00033	CcSEcCtD
Ciclesonide—Chest pain—Methotrexate—breast cancer	3.07e-05	0.000323	CcSEcCtD
Ciclesonide—Arthralgia—Methotrexate—breast cancer	3.07e-05	0.000323	CcSEcCtD
Ciclesonide—Dysgeusia—Doxorubicin—breast cancer	3.06e-05	0.000321	CcSEcCtD
Ciclesonide—Rash—Paclitaxel—breast cancer	3.04e-05	0.000319	CcSEcCtD
Ciclesonide—Dermatitis—Paclitaxel—breast cancer	3.03e-05	0.000319	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—breast cancer	3.02e-05	0.000317	CcSEcCtD
Ciclesonide—Headache—Paclitaxel—breast cancer	3.02e-05	0.000317	CcSEcCtD
Ciclesonide—Palpitations—Epirubicin—breast cancer	2.98e-05	0.000313	CcSEcCtD
Ciclesonide—Cough—Epirubicin—breast cancer	2.94e-05	0.000309	CcSEcCtD
Ciclesonide—Asthenia—Docetaxel—breast cancer	2.93e-05	0.000308	CcSEcCtD
Ciclesonide—Infection—Methotrexate—breast cancer	2.92e-05	0.000307	CcSEcCtD
Ciclesonide—Hypertension—Epirubicin—breast cancer	2.91e-05	0.000306	CcSEcCtD
Ciclesonide—Arthralgia—Epirubicin—breast cancer	2.87e-05	0.000302	CcSEcCtD
Ciclesonide—Chest pain—Epirubicin—breast cancer	2.87e-05	0.000302	CcSEcCtD
Ciclesonide—Nausea—Paclitaxel—breast cancer	2.86e-05	0.000301	CcSEcCtD
Ciclesonide—Asthenia—Capecitabine—breast cancer	2.84e-05	0.000298	CcSEcCtD
Ciclesonide—Dry mouth—Epirubicin—breast cancer	2.81e-05	0.000295	CcSEcCtD
Ciclesonide—Hydrocortisone—ABCB1—breast cancer	2.79e-05	0.0223	CrCbGaD
Ciclesonide—Palpitations—Doxorubicin—breast cancer	2.76e-05	0.00029	CcSEcCtD
Ciclesonide—Infection—Epirubicin—breast cancer	2.74e-05	0.000287	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—breast cancer	2.72e-05	0.000286	CcSEcCtD
Ciclesonide—Dizziness—Docetaxel—breast cancer	2.7e-05	0.000284	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—breast cancer	2.7e-05	0.000283	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.68e-05	0.000282	CcSEcCtD
Ciclesonide—Arthralgia—Doxorubicin—breast cancer	2.66e-05	0.000279	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—breast cancer	2.66e-05	0.000279	CcSEcCtD
Ciclesonide—Dyspnoea—Methotrexate—breast cancer	2.62e-05	0.000276	CcSEcCtD
Ciclesonide—Dizziness—Capecitabine—breast cancer	2.61e-05	0.000275	CcSEcCtD
Ciclesonide—Dry mouth—Doxorubicin—breast cancer	2.6e-05	0.000273	CcSEcCtD
Ciclesonide—Dyspepsia—Methotrexate—breast cancer	2.59e-05	0.000272	CcSEcCtD
Ciclesonide—Rash—Docetaxel—breast cancer	2.57e-05	0.000271	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—breast cancer	2.57e-05	0.00027	CcSEcCtD
Ciclesonide—Headache—Docetaxel—breast cancer	2.56e-05	0.000269	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Methotrexate—breast cancer	2.54e-05	0.000267	CcSEcCtD
Ciclesonide—Fatigue—Methotrexate—breast cancer	2.54e-05	0.000267	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—breast cancer	2.53e-05	0.000266	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.51e-05	0.000264	CcSEcCtD
Ciclesonide—Rash—Capecitabine—breast cancer	2.49e-05	0.000262	CcSEcCtD
Ciclesonide—Dermatitis—Capecitabine—breast cancer	2.49e-05	0.000262	CcSEcCtD
Ciclesonide—Headache—Capecitabine—breast cancer	2.48e-05	0.00026	CcSEcCtD
Ciclesonide—Dyspnoea—Epirubicin—breast cancer	2.46e-05	0.000258	CcSEcCtD
Ciclesonide—Nausea—Docetaxel—breast cancer	2.43e-05	0.000255	CcSEcCtD
Ciclesonide—Dyspepsia—Epirubicin—breast cancer	2.42e-05	0.000255	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Epirubicin—breast cancer	2.38e-05	0.00025	CcSEcCtD
Ciclesonide—Fatigue—Epirubicin—breast cancer	2.37e-05	0.000249	CcSEcCtD
Ciclesonide—Nausea—Capecitabine—breast cancer	2.35e-05	0.000247	CcSEcCtD
Ciclesonide—Urticaria—Methotrexate—breast cancer	2.34e-05	0.000246	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.32e-05	0.000244	CcSEcCtD
Ciclesonide—Dyspnoea—Doxorubicin—breast cancer	2.27e-05	0.000239	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—breast cancer	2.24e-05	0.000236	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—breast cancer	2.2e-05	0.000231	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—breast cancer	2.2e-05	0.000231	CcSEcCtD
Ciclesonide—Urticaria—Epirubicin—breast cancer	2.19e-05	0.00023	CcSEcCtD
Ciclesonide—Asthenia—Methotrexate—breast cancer	2.11e-05	0.000222	CcSEcCtD
Ciclesonide—Urticaria—Doxorubicin—breast cancer	2.02e-05	0.000213	CcSEcCtD
Ciclesonide—Asthenia—Epirubicin—breast cancer	1.98e-05	0.000208	CcSEcCtD
Ciclesonide—Dizziness—Methotrexate—breast cancer	1.95e-05	0.000204	CcSEcCtD
Ciclesonide—Rash—Methotrexate—breast cancer	1.86e-05	0.000195	CcSEcCtD
Ciclesonide—Dermatitis—Methotrexate—breast cancer	1.85e-05	0.000195	CcSEcCtD
Ciclesonide—Headache—Methotrexate—breast cancer	1.84e-05	0.000194	CcSEcCtD
Ciclesonide—Asthenia—Doxorubicin—breast cancer	1.83e-05	0.000192	CcSEcCtD
Ciclesonide—Dizziness—Epirubicin—breast cancer	1.82e-05	0.000191	CcSEcCtD
Ciclesonide—Nausea—Methotrexate—breast cancer	1.75e-05	0.000184	CcSEcCtD
Ciclesonide—Rash—Epirubicin—breast cancer	1.74e-05	0.000182	CcSEcCtD
Ciclesonide—Dermatitis—Epirubicin—breast cancer	1.73e-05	0.000182	CcSEcCtD
Ciclesonide—Headache—Epirubicin—breast cancer	1.73e-05	0.000181	CcSEcCtD
Ciclesonide—Dizziness—Doxorubicin—breast cancer	1.69e-05	0.000177	CcSEcCtD
Ciclesonide—Nausea—Epirubicin—breast cancer	1.64e-05	0.000172	CcSEcCtD
Ciclesonide—Rash—Doxorubicin—breast cancer	1.61e-05	0.000169	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—breast cancer	1.61e-05	0.000169	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—breast cancer	1.6e-05	0.000168	CcSEcCtD
Ciclesonide—Nausea—Doxorubicin—breast cancer	1.51e-05	0.000159	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—AR—breast cancer	1.49e-05	0.000327	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTT1—breast cancer	1.48e-05	0.000325	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	1.48e-05	0.000324	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS4X—breast cancer	1.47e-05	0.000322	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	1.46e-05	0.00032	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—breast cancer	1.46e-05	0.000319	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF3A—breast cancer	1.45e-05	0.000317	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—breast cancer	1.44e-05	0.000317	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT3A—breast cancer	1.43e-05	0.000312	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	1.42e-05	0.000312	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ELL—breast cancer	1.41e-05	0.000308	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP17A1—breast cancer	1.4e-05	0.000308	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—PTGS1—breast cancer	1.39e-05	0.000304	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	1.38e-05	0.000303	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	1.37e-05	0.0003	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1A1—breast cancer	1.37e-05	0.0003	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2D6—breast cancer	1.36e-05	0.000299	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—breast cancer	1.36e-05	0.000298	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	1.35e-05	0.000296	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	1.34e-05	0.000294	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	1.34e-05	0.000294	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—VDR—breast cancer	1.34e-05	0.000294	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—NCOA2—breast cancer	1.34e-05	0.000293	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	1.3e-05	0.000286	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PABPC1—breast cancer	1.3e-05	0.000285	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT3B—breast cancer	1.22e-05	0.000267	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL23A—breast cancer	1.19e-05	0.000262	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.18e-05	0.000259	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	1.17e-05	0.000257	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	1.17e-05	0.000257	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	1.17e-05	0.000257	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.17e-05	0.000255	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RARB—breast cancer	1.16e-05	0.000255	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.13e-05	0.000247	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS8—breast cancer	1.11e-05	0.000244	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS7—breast cancer	1.11e-05	0.000244	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MED12—breast cancer	1.11e-05	0.000244	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.11e-05	0.000243	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SYNJ2—breast cancer	1.1e-05	0.000241	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—breast cancer	1.1e-05	0.00024	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.1e-05	0.00024	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—COMT—breast cancer	1.03e-05	0.000226	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.03e-05	0.000225	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NDUFS3—breast cancer	1.02e-05	0.000224	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	1.02e-05	0.000224	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.02e-05	0.000223	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.01e-05	0.000222	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH4—breast cancer	1.01e-05	0.000221	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	9.9e-06	0.000217	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA1B—breast cancer	9.63e-06	0.000211	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CHST9—breast cancer	9.63e-06	0.000211	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	9.48e-06	0.000208	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—breast cancer	9.44e-06	0.000207	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	9.32e-06	0.000204	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PGR—breast cancer	9.23e-06	0.000202	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COX11—breast cancer	9.13e-06	0.0002	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT1—breast cancer	9.05e-06	0.000198	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A1—breast cancer	8.95e-06	0.000196	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOA2—breast cancer	8.89e-06	0.000195	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	8.83e-06	0.000193	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EZH2—breast cancer	8.77e-06	0.000192	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH3—breast cancer	8.58e-06	0.000188	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PARP1—breast cancer	8.58e-06	0.000188	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	8.42e-06	0.000184	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS6—breast cancer	8.38e-06	0.000184	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CDA—breast cancer	8.35e-06	0.000183	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SHMT1—breast cancer	8.35e-06	0.000183	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR2—breast cancer	8.13e-06	0.000178	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLCO1B1—breast cancer	8.04e-06	0.000176	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A5—breast cancer	8.04e-06	0.000176	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APRT—breast cancer	7.76e-06	0.00017	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH2—breast cancer	7.7e-06	0.000169	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOA1—breast cancer	7.49e-06	0.000164	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ESRRA—breast cancer	7.3e-06	0.00016	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ANGPTL4—breast cancer	7.3e-06	0.00016	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SYNJ2—breast cancer	7.2e-06	0.000158	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AR—breast cancer	7.18e-06	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPI—breast cancer	6.92e-06	0.000152	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HADHB—breast cancer	6.92e-06	0.000152	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NDUFS3—breast cancer	6.7e-06	0.000147	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDH1A1—breast cancer	6.6e-06	0.000145	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDH7A1—breast cancer	6.6e-06	0.000145	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SIRT1—breast cancer	6.55e-06	0.000143	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SMAD4—breast cancer	6.46e-06	0.000142	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—VDR—breast cancer	6.45e-06	0.000141	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADSL—breast cancer	6.33e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UMPS—breast cancer	6.33e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FHL2—breast cancer	6.33e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NME1—breast cancer	6.33e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PHGDH—breast cancer	6.33e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CHST9—breast cancer	6.3e-06	0.000138	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOR1—breast cancer	6.28e-06	0.000138	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HPSE—breast cancer	6.21e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BRIP1—breast cancer	6.21e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LDHB—breast cancer	6.21e-06	0.000136	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—H2AFX—breast cancer	6.12e-06	0.000134	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COX11—breast cancer	5.97e-06	0.000131	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ERCC2—breast cancer	5.9e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA3—breast cancer	5.88e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMMR—breast cancer	5.88e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCC1—breast cancer	5.88e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARGC1B—breast cancer	5.7e-06	0.000125	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CDA—breast cancer	5.46e-06	0.00012	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SHMT1—breast cancer	5.46e-06	0.00012	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA9—breast cancer	5.38e-06	0.000118	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA4—breast cancer	5.38e-06	0.000118	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	5.33e-06	0.000117	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A5—breast cancer	5.25e-06	0.000115	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLCO1B1—breast cancer	5.25e-06	0.000115	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA2—breast cancer	5.24e-06	0.000115	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX2—breast cancer	5.24e-06	0.000115	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SULT1A1—breast cancer	5.18e-06	0.000113	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX4—breast cancer	5.18e-06	0.000113	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APRT—breast cancer	5.08e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—IDH1—breast cancer	5.06e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA1—breast cancer	5.06e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NAT2—breast cancer	5e-06	0.00011	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR1—breast cancer	4.93e-06	0.000108	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ESRRA—breast cancer	4.77e-06	0.000105	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.77e-06	0.000105	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH1—breast cancer	4.77e-06	0.000104	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPI—breast cancer	4.52e-06	9.91e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HADHB—breast cancer	4.52e-06	9.91e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DPYD—breast cancer	4.39e-06	9.61e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MED12—breast cancer	4.39e-06	9.61e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDOA—breast cancer	4.32e-06	9.46e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDH1A1—breast cancer	4.32e-06	9.46e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDH7A1—breast cancer	4.32e-06	9.46e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA3—breast cancer	4.19e-06	9.18e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A2—breast cancer	4.16e-06	9.12e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UMPS—breast cancer	4.14e-06	9.06e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FHL2—breast cancer	4.14e-06	9.06e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PHGDH—breast cancer	4.14e-06	9.06e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NME1—breast cancer	4.14e-06	9.06e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADSL—breast cancer	4.14e-06	9.06e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CPT1A—breast cancer	4.08e-06	8.93e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTR—breast cancer	4.08e-06	8.93e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG2—breast cancer	4.08e-06	8.93e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BRIP1—breast cancer	4.06e-06	8.89e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HPSE—breast cancer	4.06e-06	8.89e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LDHB—breast cancer	4.06e-06	8.89e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SERPINE1—breast cancer	4.05e-06	8.88e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HPGDS—breast cancer	4e-06	8.76e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HBA1—breast cancer	3.97e-06	8.71e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—breast cancer	3.88e-06	8.5e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACHE—breast cancer	3.88e-06	8.5e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCC1—breast cancer	3.85e-06	8.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA3—breast cancer	3.85e-06	8.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMMR—breast cancer	3.85e-06	8.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.72e-06	8.16e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP17A1—breast cancer	3.67e-06	8.04e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENO1—breast cancer	3.63e-06	7.96e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS1—breast cancer	3.63e-06	7.96e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA9—breast cancer	3.52e-06	7.71e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA4—breast cancer	3.52e-06	7.71e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA2—breast cancer	3.5e-06	7.67e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA2—breast cancer	3.43e-06	7.51e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX2—breast cancer	3.43e-06	7.51e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FASN—breast cancer	3.39e-06	7.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX4—breast cancer	3.39e-06	7.42e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SULT1A1—breast cancer	3.39e-06	7.42e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BCHE—breast cancer	3.38e-06	7.4e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A5—breast cancer	3.34e-06	7.31e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—IDH1—breast cancer	3.31e-06	7.25e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA1—breast cancer	3.31e-06	7.25e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NAT2—breast cancer	3.27e-06	7.17e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NQO1—breast cancer	3.22e-06	7.06e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A1—breast cancer	3.22e-06	7.06e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP3A4—breast cancer	3.14e-06	6.89e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1B1—breast cancer	3.09e-06	6.77e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.03e-06	6.64e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA1—breast cancer	2.95e-06	6.46e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP19A1—breast cancer	2.91e-06	6.37e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—STK11—breast cancer	2.91e-06	6.37e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MED12—breast cancer	2.87e-06	6.28e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DPYD—breast cancer	2.87e-06	6.28e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDOA—breast cancer	2.82e-06	6.19e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA3—breast cancer	2.74e-06	6e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A2—breast cancer	2.72e-06	5.96e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COMT—breast cancer	2.7e-06	5.92e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—breast cancer	2.69e-06	5.89e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG2—breast cancer	2.67e-06	5.84e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CPT1A—breast cancer	2.67e-06	5.84e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTR—breast cancer	2.67e-06	5.84e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—breast cancer	2.65e-06	5.81e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ITPR1—breast cancer	2.65e-06	5.8e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—breast cancer	2.64e-06	5.78e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HPGDS—breast cancer	2.61e-06	5.73e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HBA1—breast cancer	2.6e-06	5.69e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—breast cancer	2.56e-06	5.62e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCB1—breast cancer	2.54e-06	5.58e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACHE—breast cancer	2.54e-06	5.56e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—breast cancer	2.54e-06	5.56e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMS—breast cancer	2.5e-06	5.48e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—breast cancer	2.47e-06	5.41e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.47e-06	5.41e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOR1—breast cancer	2.47e-06	5.41e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP17A1—breast cancer	2.4e-06	5.26e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENO1—breast cancer	2.38e-06	5.21e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS1—breast cancer	2.38e-06	5.21e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX1—breast cancer	2.37e-06	5.18e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A1—breast cancer	2.34e-06	5.13e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2D6—breast cancer	2.33e-06	5.11e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ERCC2—breast cancer	2.32e-06	5.09e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA2—breast cancer	2.29e-06	5.01e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FASN—breast cancer	2.22e-06	4.86e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BCHE—breast cancer	2.21e-06	4.84e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—breast cancer	2.18e-06	4.78e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A5—breast cancer	2.18e-06	4.78e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A1—breast cancer	2.11e-06	4.62e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NQO1—breast cancer	2.11e-06	4.62e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.02e-06	4.43e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAV1—breast cancer	2.01e-06	4.41e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.98e-06	4.34e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA1—breast cancer	1.93e-06	4.22e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—STK11—breast cancer	1.9e-06	4.16e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP19A1—breast cancer	1.9e-06	4.16e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—breast cancer	1.83e-06	4.02e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—breast cancer	1.78e-06	3.9e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COMT—breast cancer	1.77e-06	3.87e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—breast cancer	1.76e-06	3.85e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—breast cancer	1.73e-06	3.8e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ITPR1—breast cancer	1.73e-06	3.79e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCB1—breast cancer	1.66e-06	3.65e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMS—breast cancer	1.63e-06	3.58e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOR1—breast cancer	1.62e-06	3.54e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.62e-06	3.54e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—breast cancer	1.62e-06	3.54e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CD—breast cancer	1.61e-06	3.53e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—breast cancer	1.59e-06	3.49e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX1—breast cancer	1.55e-06	3.39e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.53e-06	3.35e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NOS3—breast cancer	1.52e-06	3.34e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ERCC2—breast cancer	1.52e-06	3.33e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—breast cancer	1.43e-06	3.13e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CB—breast cancer	1.41e-06	3.08e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—breast cancer	1.39e-06	3.05e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAV1—breast cancer	1.32e-06	2.88e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—breast cancer	1.21e-06	2.66e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.2e-06	2.63e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.05e-06	2.31e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—breast cancer	1.04e-06	2.28e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NOS3—breast cancer	9.96e-07	2.18e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CB—breast cancer	9.19e-07	2.01e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—breast cancer	9.11e-07	2e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—breast cancer	8.57e-07	1.88e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—breast cancer	7.94e-07	1.74e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—breast cancer	7e-07	1.53e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—breast cancer	5.6e-07	1.23e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—breast cancer	4.58e-07	1e-05	CbGpPWpGaD
